Completed PHASE3 INTERVENTIONAL 1-arm NCT00522275

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

An Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral SPM 927 in Patients With Partial Seizures

Sponsor: UCB BIOSCIENCES, Inc.

Conditions Partial Epilepsies

Interventions lacosamide

Updated 9 times since 2017 Last updated: Jun 20, 2018 Started: Oct 31, 2004 Primary completion: Oct 31, 2009 Completion: Oct 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00522275, this PHASE3 trial focuses on Partial Epilepsies and remains completed. Sponsored by UCB BIOSCIENCES, Inc., it has been updated 9 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Aug 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Jun 2018 — Aug 2018 [monthly]

Completed PHASE3
Sep 2017 — Jun 2018 [monthly]

Completed PHASE3
Feb 2017 — Sep 2017 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

UCB BIOSCIENCES, Inc.

Data source: UCB Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Asheville, United States , Atlanta, United States , Baltimore, United States , Beaufort, United States , Bethesda, United States , Birmingham, United States , Boston, United States , Bradenton, United States , Buffalo, United States and 50 more locations